Coya Therapeutics shares its Q3 2026 financial results, highlighting operational updates and strategic direction in the pharmaceutical preparations sector.
| Name | Coya Therapeutics, Inc. |
|---|---|
| CIK | 0001835022 |
| Tickers | COYA |
| Exchanges | Nasdaq |
| Entity type | operating |
| Category | Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company |
| SIC | 2834 Pharmaceutical Preparations |
| EIN | 000000000 |
| LEI | — |
| Fiscal year end | 1231 |
| State of incorporation | DE DE |
| Phone | 650.739.3939 |
| Website | — |
| Investor website | — |
| Owner org | 03 Life Sciences |
| Flags | — |
| Description | — |
| Insider transactions (issuer) | 1 |
| Insider transactions (owner) | 0 |
EDGAR has no company-logo API. Website field is shown when the filer provided one.
Coya Therapeutics shares its Q3 2026 financial results, highlighting operational updates and strategic direction in the pharmaceutical preparations sector.
Coya Therapeutics, Inc. announces its financial results for Q3 2026, providing insights into its operations and performance in the pharmaceutical industry.
Coya Therapeutics announces plans for an open-label extension of its ALS trial for COYA 302, responding to participant requests for continued treatment.
Coya Therapeutics announces full enrollment in its Phase 2/3 ALSTARS Trial for COYA 302, aimed at treating ALS, with data expected in early Q2 2027.
232 filing rows loaded from submissions recent.
| Filed | Form | Document | Items | Accession | File no. | Film | Act | Size | XBRL | iXBRL |
|---|---|---|---|---|---|---|---|---|---|---|
| 2026-11-10 | 10-Q | 10-Q | 0001193125-26-454478 | 001-41583 | 261538060 | 34 | 7504496 | 1 | 1 | |
| 2026-11-10 | 8-K | 8-K | 2.02,9.01 | 0001193125-26-454473 | 001-41583 | 261538042 | 34 | 453829 | 1 | 1 |
| 2026-10-14 | 8-K | 8-K | 8.01 | 0001193125-26-421066 | 001-41583 | 261458360 | 34 | 148432 | 1 | 1 |
| 2026-10-05 | 8-K | 8-K | 8.01 | 0001193125-26-413218 | 001-41583 | 261438859 | 34 | 146439 | 1 | 1 |
| 2026-09-15 | 8-K | 8-K | 8.01 | 0001193125-26-391378 | 001-41583 | 261379182 | 34 | 146827 | 1 | 1 |
| 2026-08-11 | 10-Q | 10-Q | 0001193125-26-343481 | 001-41583 | 261260698 | 34 | 7156664 | 1 | 1 | |
| 2026-08-11 | 8-K | 8-K | 2.02,9.01 | 0001193125-26-343473 | 001-41583 | 261260686 | 34 | 452607 | 1 | 1 |
| 2026-08-07 | 8-K/A | 8-K/A | 5.02 | 0001193125-26-340449 | 001-41583 | 261255206 | 34 | 146568 | 1 | 1 |
| 2026-07-27 | SCHEDULE 13G/A | xslSCHEDULE_13G_X02/primary_doc.xml | 0001493152-26-034737 | 005-93853 | 261203443 | 34 | 9358 | |||
| 2026-06-25 | 8-K | 8-K | 5.07 | 0001193125-26-282989 | 001-41583 | 261122834 | 34 | 146113 | 1 | 1 |
| 2026-05-13 | ARS | ARS | 0001193125-26-220695 | 001-41583 | 26971079 | 34 | 2924296 | |||
| 2026-05-13 | DEFA14A | DEFA14A | 0001193125-26-220690 | 001-41583 | 26971063 | 34 | 644957 | |||
| 2026-05-13 | DEF 14A | DEF 14A | 0001193125-26-220688 | 001-41583 | 26971056 | 34 | 1981197 | 1 | 1 | |
| 2026-05-12 | 8-K | 8-K | 1.01,9.01 | 0001193125-26-218282 | 001-41583 | 26966044 | 34 | 464848 | 1 | 1 |
| 2026-05-12 | 424B5 | 424B5 | 0001193125-26-218278 | 333-289511 | 26966036 | 33 | 458070 | |||
| 2026-05-12 | 10-Q | 10-Q | 0001193125-26-218201 | 001-41583 | 26965900 | 34 | 6586754 | 1 | 1 | |
| 2026-05-12 | 8-K | 8-K | 2.02,8.01,9.01 | 0001193125-26-218198 | 001-41583 | 26965896 | 34 | 453035 | 1 | 1 |
| 2026-04-09 | 4 | 4 | 0001193125-26-149968 | 5281 | ||||||
| 2026-04-09 | 3 | 3 | 0001193125-26-149960 | 14991 | ||||||
| 2026-04-02 | 8-K | 8-K | 5.02,9.01 | 0001193125-26-139094 | 001-41583 | 26830788 | 34 | 240811 | 1 | 1 |
| 2026-03-20 | EFFECT | xslEFFECTX01/primary_doc.xml | ,, | 9999999995-26-000895 | 333-294315 | 26779757 | 33 | 1733 | ||
| 2026-03-20 | 424B3 | 424B3 | 0001193125-26-117738 | 333-294315 | 26778613 | 33 | 230864 | |||
| 2026-03-19 | CORRESP | filename1.htm | 0001193125-26-115931 | 5316 | ||||||
| 2026-03-19 | UPLOAD | filename1.pdf | 0000000000-26-002775 | 333-294315 | 40051 | |||||
| 2026-03-16 | S-3 | S-3 | 0001193125-26-107413 | 333-294315 | 26754760 | 33 | 429129 | 1 | 1 | |
| 2026-03-16 | 10-K | 10-K | 0001193125-26-107281 | 001-41583 | 26754552 | 34 | 29865077 | 1 | 1 | |
| 2026-03-16 | 8-K | 8-K | 2.02,9.01 | 0001193125-26-107276 | 001-41583 | 26754544 | 34 | 462322 | 1 | 1 |
| 2026-03-12 | SCHEDULE 13G | xslSCHEDULE_13G_X01/primary_doc.xml | 0001575872-26-000104 | 005-93853 | 26747168 | 34 | 12459 | |||
| 2026-01-30 | SCHEDULE 13G/A | xslSCHEDULE_13G_X01/primary_doc.xml | 0000102909-26-000083 | 005-93853 | 26581897 | 34 | 7046 | |||
| 2026-01-30 | 8-K | 8-K | 1.01,3.02,7.01,8.01,9.01 | 0001193125-26-030531 | 001-41583 | 26580592 | 34 | 457409 | 1 | 1 |
| 2026-01-28 | SCHEDULE 13G/A | xslSCHEDULE_13G_X01/primary_doc.xml | 0001493152-26-003978 | 005-93853 | 26571528 | 34 | 9281 | |||
| 2026-01-26 | 4 | 4 | 0001193125-26-021729 | 5440 | ||||||
| 2026-01-26 | 4 | 4 | 0001193125-26-021728 | 5493 | ||||||
| 2026-01-26 | 4 | 4 | 0001193125-26-021725 | 5483 | ||||||
| 2026-01-26 | 4 | 4 | 0001193125-26-021724 | 5468 | ||||||
| 2026-01-20 | 8-K | 8-K | 8.01 | 0001193125-26-016017 | 001-41583 | 26541195 | 34 | 139696 | 1 | 1 |
| 2026-01-08 | 8-K | 8-K | 8.01 | 0001193125-26-007042 | 001-41583 | 26517490 | 34 | 144226 | 1 | 1 |
| 2026-01-06 | 4 | 4 | 0001193125-26-005024 | 5199 | ||||||
| 2026-01-06 | 4 | 4 | 0001193125-26-005023 | 5224 | ||||||
| 2026-01-06 | 4 | 4 | 0001193125-26-005022 | 5171 | ||||||
| 2026-01-06 | 4 | 4 | 0001193125-26-005018 | 5143 | ||||||
| 2026-01-06 | 4 | 4 | 0001193125-26-005015 | 5175 | ||||||
| 2025-12-17 | 8-K | 8-K | 8.01 | 0001193125-25-321737 | 001-41583 | 251577275 | 34 | 139495 | 1 | 1 |
| 2025-11-12 | 10-Q | 10-Q | 0001193125-25-276058 | 001-41583 | 251469162 | 34 | 7542951 | 1 | 1 | |
| 2025-11-12 | 8-K | 8-K | 2.02,7.01,9.01 | 0001193125-25-276022 | 001-41583 | 251469093 | 34 | 451308 | 1 | 1 |
| 2025-10-27 | 8-K | 8-K | 1.01,3.02,7.01,9.01 | 0001193125-25-250709 | 001-41583 | 251417487 | 34 | 558069 | 1 | 1 |
| 2025-10-27 | 424B5 | 424B5 | 0001193125-25-250699 | 333-289511 | 251417478 | 33 | 553218 | |||
| 2025-10-23 | 424B5 | 424B5 | 0001193125-25-248847 | 333-289511 | 251413558 | 33 | 553469 | |||
| 2025-09-02 | 8-K | 8-K | 8.01 | 0001193125-25-193450 | 001-41583 | 251283089 | 34 | 140617 | 1 | 1 |
| 2025-08-19 | EFFECT | xslEFFECTX01/primary_doc.xml | ,, | 9999999995-25-002680 | 333-289511 | 251233721 | 33 | 1734 | ||
| 2025-08-19 | 424B7 | 424B7 | 0001193125-25-183460 | 333-289511 | 251232230 | 33 | 359107 | |||
| 2025-08-19 | 4 | 4 | 0001641172-25-024820 | 6897 | ||||||
| 2025-08-18 | CORRESP | filename1.htm | 0001193125-25-182618 | 6351 | ||||||
| 2025-08-13 | UPLOAD | filename1.pdf | 0000000000-25-008542 | 333-289511 | 40099 | |||||
| 2025-08-12 | S-3 | S-3 | 0001193125-25-178531 | 333-289511 | 251204180 | 33 | 1375367 | 1 | 1 | |
| 2025-08-12 | 10-Q | 10-Q | 0000950170-25-106934 | 001-41583 | 251204134 | 34 | 7162790 | 1 | 1 | |
| 2025-08-12 | 8-K | 8-K | 2.02,7.01,9.01 | 0000950170-25-106932 | 001-41583 | 251204131 | 34 | 459059 | 1 | 1 |
| 2025-07-29 | 8-K | 8-K | 8.01 | 0001193125-25-168115 | 001-41583 | 251162910 | 34 | 140036 | 1 | 1 |
| 2025-07-01 | 8-K | 8-K | 8.01 | 0001193125-25-153465 | 001-41583 | 251094193 | 34 | 139894 | 1 | 1 |
| 2025-06-26 | 8-K | 8-K | 5.07 | 0001193125-25-149104 | 001-41583 | 251081154 | 34 | 147341 | 1 | 1 |
| 2025-05-16 | ARS | ARS | 0001193125-25-121800 | 001-41583 | 25960467 | 34 | 53607434 | |||
| 2025-05-16 | DEFA14A | DEFA14A | 0001193125-25-121786 | 001-41583 | 25960391 | 34 | 221332 | |||
| 2025-05-16 | DEF 14A | DEF 14A | 0001193125-25-121779 | 001-41583 | 25960307 | 34 | 2107533 | 1 | 1 | |
| 2025-05-13 | 10-Q | 10-Q | 0000950170-25-069824 | 001-41583 | 25937281 | 34 | 6488760 | 1 | 1 | |
| 2025-05-13 | 8-K | 8-K | 2.02,7.01,9.01 | 0000950170-25-069819 | 001-41583 | 25937249 | 34 | 458838 | 1 | 1 |
| 2025-04-28 | 10-K/A | 10-K/A | 0001193125-25-100816 | 001-41583 | 25881469 | 34 | 887469 | 1 | 1 | |
| 2025-03-18 | 10-K | 10-K | 0000950170-25-040782 | 001-41583 | 25746560 | 34 | 25100475 | 1 | 1 | |
| 2025-03-18 | 8-K | 8-K | 2.02,7.01,9.01 | 0000950170-25-040779 | 001-41583 | 25746558 | 34 | 477528 | 1 | 1 |
| 2025-02-25 | 4 | 4 | 0000950170-25-027255 | 5134 | ||||||
| 2025-02-25 | 4 | 4 | 0000950170-25-027254 | 5158 | ||||||
| 2025-02-25 | 4 | 4 | 0000950170-25-027253 | 5038 | ||||||
| 2025-02-25 | 4 | 4 | 0000950170-25-027252 | 5130 | ||||||
| 2025-02-25 | 4 | 4 | 0000950170-25-027251 | 5102 | ||||||
| 2025-02-14 | SCHEDULE 13G/A | xslSCHEDULE_13G_X01/primary_doc.xml | 0000929638-25-000790 | 005-93853 | 25629465 | 34 | 12436 | |||
| 2025-02-10 | SCHEDULE 13G/A | xslSCHEDULE_13G_X01/primary_doc.xml | 0001493152-25-005549 | 005-93853 | 25603767 | 34 | 9551 | |||
| 2025-01-30 | S-8 | S-8 | 0001193125-25-017337 | 333-284609 | 25574680 | 33 | 64945 | |||
| 2025-01-13 | 4 | 4 | 0000950170-25-004575 | 5184 | ||||||
| 2025-01-13 | 4 | 4 | 0000950170-25-004573 | 5230 | ||||||
| 2025-01-13 | 4 | 4 | 0000950170-25-004572 | 5252 | ||||||
| 2025-01-13 | 4 | 4 | 0000950170-25-004571 | 5189 | ||||||
| 2025-01-03 | 4 | 4 | 0000950170-25-001571 | 5080 | ||||||
| 2025-01-03 | 4 | 4 | 0000950170-25-001570 | 5144 | ||||||
| 2025-01-03 | 4 | 4 | 0000950170-25-001569 | 5176 | ||||||
| 2025-01-03 | 4 | 4 | 0000950170-25-001568 | 5200 | ||||||
| 2025-01-03 | 4 | 4 | 0000950170-25-001567 | 5172 | ||||||
| 2024-11-29 | EFFECT | xslEFFECTX01/primary_doc.xml | S-3,,2024-11-29 16:00:00 | 9999999995-24-003622 | 333-283366 | 241517287 | 33 | 1741 | ||
| 2024-11-29 | 424B3 | 424B3 | 0001193125-24-268100 | 333-283366 | 241516542 | 33 | 232941 | |||
| 2024-11-26 | CORRESP | filename1.htm | 0001193125-24-266104 | 5792 | ||||||
| 2024-11-25 | UPLOAD | filename1.pdf | 0000000000-24-013046 | 333-283366 | 40030 | |||||
| 2024-11-20 | S-3 | S-3 | 0001193125-24-262623 | 333-283366 | 241481338 | 33 | 319742 | |||
| 2024-11-14 | 4 | xslF345X05/ownership.xml | 0001493152-24-046106 | 4495 | ||||||
| 2024-11-13 | 4 | xslF345X05/ownership.xml | 0001493152-24-045120 | 4544 | ||||||
| 2024-11-12 | 4 | xslF345X05/ownership.xml | 0001493152-24-044896 | 4562 | ||||||
| 2024-11-12 | 4 | xslF345X05/ownership.xml | 0001493152-24-044819 | 4543 | ||||||
| 2024-11-12 | SC 13G/A | UnitedStates_13G__CoyaTherap.txt | 0000932471-24-001003 | 005-93853 | 241447468 | 34 | 6515 | |||
| 2024-11-06 | 10-Q | 10-Q | 0000950170-24-121837 | 001-41583 | 241429319 | 34 | 5782492 | 1 | 1 | |
| 2024-11-06 | 8-K | 8-K | 2.02,7.01,9.01 | 0000950170-24-121833 | 001-41583 | 241429297 | 34 | 437980 | 1 | 1 |
| 2024-11-05 | 8-K | 8-K | 5.02 | 0001193125-24-251319 | 001-41583 | 241428421 | 34 | 147227 | 1 | 1 |
| 2024-11-04 | SC 13G/A | UnitedStates_13G__CoyaTherap.txt | 0000932471-24-000368 | 005-93853 | 241422182 | 34 | 5593 | |||
| 2024-11-04 | SC 13G/A | UnitedStates_13G__CoyaTherap.txt | 0000932471-24-000408 | 005-93853 | 241421654 | 34 | 5593 | |||
| 2024-10-31 | 8-K | 8-K | 5.02,9.01 | 0001193125-24-248755 | 001-41583 | 241415809 | 34 | 277632 | 1 | 1 |
| 2024-10-29 | 8-K | 8-K | 7.01,9.01 | 0001193125-24-246171 | 001-41583 | 241402731 | 34 | 2622276 | 1 | 1 |
| 2024-10-28 | D | xslFormDX01/primary_doc.xml | 06b | 0001493152-24-042710 | 021-527969 | 241401621 | 33 | 15358 | ||
| 2024-10-22 | 8-K | 8-K | 1.01,3.02,7.01,8.01,9.01 | 0001193125-24-240775 | 001-41583 | 241384830 | 34 | 493033 | 1 | 1 |
| 2024-08-20 | 3 | xslF345X02/ownership.xml | 0001493152-24-033261 | 14799 | ||||||
| 2024-08-19 | 8-K | 8-K | 5.02,7.01,9.01 | 0001193125-24-202551 | 001-41583 | 241218411 | 34 | 238114 | 1 | 1 |
| 2024-08-12 | 10-Q | 10-Q | 0000950170-24-095075 | 001-41583 | 241194813 | 34 | 5630195 | 1 | 1 | |
| 2024-08-12 | 8-K | 8-K | 2.02,7.01,9.01 | 0000950170-24-095072 | 001-41583 | 241194792 | 34 | 436156 | 1 | 1 |
| 2024-07-15 | 8-K | 8-K | 8.01 | 0001193125-24-178809 | 001-41583 | 241115795 | 34 | 148085 | 1 | 1 |
| 2024-06-24 | 424B3 | 424B3 | 0001193125-24-167085 | 333-280235 | 241065491 | 33 | 247452 | |||
| 2024-06-21 | EFFECT | xslEFFECTX01/primary_doc.xml | S-3,,2024-06-21 17:00:00 | 9999999995-24-001918 | 333-280235 | 241061879 | 33 | 1741 | ||
| 2024-06-20 | CORRESP | filename1.htm | 0001193125-24-164441 | 5237 | ||||||
| 2024-06-18 | UPLOAD | filename1.pdf | 0000000000-24-006981 | 333-280235 | 40271 | |||||
| 2024-06-14 | S-3 | S-3 | 0001193125-24-161701 | 333-280235 | 241045775 | 33 | 350022 | |||
| 2024-06-05 | 4 | 4 | 0000950170-24-069551 | 5164 | ||||||
| 2024-06-05 | 4 | 4 | 0000950170-24-069550 | 5236 | ||||||
| 2024-06-05 | 4 | 4 | 0000950170-24-069549 | 5231 | ||||||
| 2024-06-05 | 8-K | 8-K | 1.01,9.01 | 0001193125-24-154729 | 001-41583 | 241020788 | 34 | 163194 | 1 | 1 |
| 2024-05-20 | 8-K | 8-K | 1.01,3.02,7.01,9.01 | 0001193125-24-142950 | 001-41583 | 24965501 | 34 | 550377 | 1 | 1 |
| 2024-05-09 | 10-Q | 10-Q | 0000950170-24-057056 | 001-41583 | 24931150 | 34 | 4862479 | 1 | 1 | |
| 2024-05-09 | 8-K | 8-K | 2.02,7.01,9.01 | 0000950170-24-057018 | 001-41583 | 24931028 | 34 | 392611 | 1 | 1 |
| 2024-05-08 | 8-K | 8-K | 5.02,5.07,9.01 | 0001193125-24-134376 | 001-41583 | 24927584 | 34 | 173088 | 1 | 1 |
| 2024-03-29 | DEFA14A | DEFA14A | 0000950170-24-038250 | 001-41583 | 24801053 | 34 | 749640 | |||
| 2024-03-28 | ARS | ARS | 0000950170-24-038118 | 001-41583 | 24799793 | 34 | 2895088 | |||
| 2024-03-28 | DEFA14A | DEFA14A | 0000950170-24-038112 | 001-41583 | 24799715 | 34 | 824334 | |||
| 2024-03-28 | DEF 14A | DEF 14A | 0000950170-24-038090 | 001-41583 | 24799555 | 34 | 812359 | |||
| 2024-03-19 | 10-K | 10-K | 0000950170-24-033161 | 001-41583 | 24761165 | 34 | 13162014 | 1 | 1 | |
| 2024-03-19 | 8-K | 8-K | 2.02,7.01,9.01 | 0000950170-24-033159 | 001-41583 | 24761161 | 34 | 438350 | 1 | 1 |
| 2024-03-05 | 4 | xslF345X05/ownership.xml | 0001493152-24-008916 | 5047 | ||||||
| 2024-02-14 | SC 13G/A | AMENDMENT NO. 1 | 0000929638-24-000705 | 005-93853 | 24639650 | 34 | 81668 | |||
| 2024-02-07 | SC 13G/A | formsc13ga.htm | 0001493152-24-005327 | 005-93853 | 24606307 | 34 | 104516 | |||
| 2024-02-02 | 4 | xslF345X05/ownership.xml | 0001493152-24-004813 | 7732 | ||||||
| 2024-02-02 | 4 | xslF345X05/ownership.xml | 0001493152-24-004815 | 5313 | ||||||
| 2024-02-02 | 4 | xslF345X05/ownership.xml | 0001493152-24-004814 | 5417 | ||||||
| 2024-01-19 | 4 | xslF345X05/ownership.xml | 0001493152-24-003109 | 5385 | ||||||
| 2024-01-19 | 4 | xslF345X05/ownership.xml | 0001493152-24-003111 | 5410 | ||||||
| 2024-01-19 | 4 | xslF345X05/ownership.xml | 0001493152-24-003110 | 5293 | ||||||
| 2024-01-19 | 4 | xslF345X05/ownership.xml | 0001493152-24-003108 | 5389 | ||||||
| 2024-01-19 | 4 | xslF345X05/ownership.xml | 0001493152-24-003107 | 5413 | ||||||
| 2024-01-19 | 8-K | 8-K | 8.01 | 0001193125-24-010775 | 001-41583 | 24543788 | 34 | 153867 | 1 | 1 |
| 2024-01-16 | 424B3 | 424B3 | 0001193125-24-008554 | 333-276374 | 24535205 | 33 | 478234 | |||
| 2024-01-12 | EFFECT | xslEFFECTX01/primary_doc.xml | S-3,,2024-01-12 17:00:00 | 9999999995-24-000119 | 333-276374 | 24533471 | 33 | 1740 | ||
| 2024-01-10 | CORRESP | filename1.htm | 0001193125-24-006011 | 5292 | ||||||
| 2024-01-09 | UPLOAD | filename1.pdf | 0000000000-24-000304 | 333-276374 | 40296 | |||||
| 2024-01-04 | S-3 | S-3 | 0001193125-24-002488 | 333-276374 | 24512795 | 33 | 573885 | |||
| 2024-01-04 | 4 | xslF345X05/ownership.xml | 0001493152-24-001080 | 5366 | ||||||
| 2023-12-29 | 3 | xslF345X02/ownership.xml | 0001493152-23-046474 | 10590 | ||||||
| 2023-12-20 | D | xslFormDX01/primary_doc.xml | 06b | 0001493152-23-045524 | 021-500218 | 231499679 | 33 | 14096 | ||
| 2023-12-20 | 8-K | 8-K | 5.02,7.01,9.01 | 0001193125-23-299370 | 001-41583 | 231499457 | 34 | 175137 | 1 | 1 |
| 2023-12-12 | SC 13G | sch13g.htm | 0000929638-23-003417 | 005-93853 | 231481241 | 34 | 116591 | |||
| 2023-12-06 | 8-K | 8-K | 1.01,3.02,7.01,8.01,9.01 | 0001193125-23-289550 | 001-41583 | 231468421 | 34 | 1077393 | 1 | 1 |
| 2023-11-08 | 10-Q | 10-Q | 0000950170-23-060718 | 001-41583 | 231386253 | 34 | 5795459 | 1 | 1 | |
| 2023-11-08 | 8-K | 8-K | 2.02,7.01,9.01 | 0000950170-23-060716 | 001-41583 | 231386246 | 34 | 386464 | 1 | 1 |
| 2023-08-21 | 4 | FORM 4 SUBMISSION | 0000899243-23-018335 | 5138 | ||||||
| 2023-08-21 | 3 | FORM 3 SUBMISSION | 0000899243-23-018334 | 6241 | ||||||
| 2023-08-21 | 8-K | 8-K | 5.02,7.01,9.01 | 0001193125-23-217039 | 001-41583 | 231189854 | 34 | 174173 | 1 | 1 |
| 2023-08-08 | 10-Q | 10-Q | 0000950170-23-039354 | 001-41583 | 231149280 | 34 | 6161978 | 1 | 1 | |
| 2023-08-08 | 8-K | 8-K | 2.02,7.01,9.01 | 0000950170-23-039348 | 001-41583 | 231149260 | 34 | 403812 | 1 | 1 |
| 2023-07-19 | 4 | xslF345X05/ownership.xml | 0001493152-23-024969 | 5422 | ||||||
| 2023-07-19 | 3 | xslF345X02/ownership.xml | 0001493152-23-024968 | 9728 | ||||||
| 2023-07-14 | 8-K | 8-K | 5.02,9.01 | 0001193125-23-187328 | 001-41583 | 231089695 | 34 | 208496 | 1 | 1 |
| 2023-07-10 | 8-K | 8-K | 5.02,9.01 | 0001193125-23-184752 | 001-41583 | 231080503 | 34 | 202851 | 1 | 1 |
| 2023-06-29 | 8-K | 8-K | 5.07 | 0001193125-23-178604 | 001-41583 | 231057579 | 34 | 152557 | 1 | 1 |
| 2023-06-12 | 8-K | 8-K | 7.01,9.01 | 0001193125-23-165406 | 001-41583 | 231008905 | 34 | 183521 | 1 | 1 |
| 2023-05-23 | 8-K | 8-K | 8.01 | 0001193125-23-151872 | 001-41583 | 23949448 | 34 | 148724 | 1 | 1 |
| 2023-05-19 | DEFA14A | DEFA14A | 0001193125-23-149413 | 001-41583 | 23940966 | 34 | 95606 | |||
| 2023-05-19 | ARS | ARS | 0001193125-23-149397 | 001-41583 | 23940835 | 34 | 1041526 | |||
| 2023-05-19 | DEF 14A | DEF 14A | 0001193125-23-149377 | 001-41583 | 23940725 | 34 | 484243 | |||
| 2023-05-16 | 8-K | 8-K | 7.01,8.01,9.01 | 0001193125-23-145650 | 001-41583 | 23925590 | 34 | 1183923 | 1 | 1 |
| 2023-05-12 | 424B4 | 424B4 | 0001193125-23-143489 | 333-268482 | 23915939 | 33 | 142821 | |||
| 2023-05-10 | EFFECT | xslEFFECTX01/primary_doc.xml | POS AM,0001193125-23-137754,2023-05-10 | 9999999995-23-001362 | 333-268482 | 23908608 | 33 | 1704 | ||
| 2023-05-10 | 10-Q | 10-Q | 0000950170-23-020076 | 001-41583 | 23904319 | 34 | 5939869 | 1 | 1 | |
| 2023-05-10 | 8-K | 8-K | 2.02,9.01 | 0000950170-23-020073 | 001-41583 | 23904310 | 34 | 409828 | 1 | 1 |
| 2023-05-08 | POS AM | POS AM | 0001193125-23-137754 | 333-268482 | 23896083 | 33 | 217197 | |||
| 2023-05-01 | 10-K/A | 10-K/A | 0001193125-23-130647 | 001-41583 | 23874982 | 34 | 501335 | 1 | 1 | |
| 2023-04-14 | S-8 | S-8 | 0001193125-23-102073 | 333-271264 | 23821290 | 33 | 89487 | |||
| 2023-03-29 | 10-K | 10-K | 0000950170-23-010599 | 001-41583 | 23775276 | 34 | 11287527 | 1 | 1 | |
| 2023-03-29 | 8-K | 8-K | 2.02,9.01 | 0000950170-23-010589 | 001-41583 | 23775191 | 34 | 380859 | 1 | 1 |
| 2023-03-22 | 8-K | 8-K | 1.01 | 0001193125-23-076795 | 001-41583 | 23753601 | 34 | 151781 | 1 | 1 |
| 2023-03-21 | 8-K | 8-K | 7.01,9.01 | 0001193125-23-075260 | 001-41583 | 23747854 | 34 | 6779868 | 1 | 1 |
| 2023-03-13 | 8-K | 8-K | 7.01 | 0001193125-23-068453 | 001-41583 | 23725658 | 34 | 148187 | 1 | 1 |
| 2023-03-01 | 8-K | 8-K | 5.02 | 0001193125-23-056314 | 001-41583 | 23693489 | 34 | 148283 | 1 | 1 |
| 2023-03-01 | 4 | xslF345X03/ownership.xml | 0001493152-23-006392 | 5292 | ||||||
| 2023-03-01 | 4 | xslF345X03/ownership.xml | 0001493152-23-006390 | 5289 | ||||||
| 2023-03-01 | 4 | xslF345X03/ownership.xml | 0001493152-23-006389 | 5222 | ||||||
| 2023-02-14 | SC 13G/A | formsc13ga.htm | 0001493152-23-004955 | 005-93853 | 23630419 | 34 | 84006 | |||
| 2023-02-14 | SC 13G | formsc13g.htm | 0001493152-23-004869 | 005-93853 | 23628877 | 34 | 90510 | |||
| 2023-01-25 | 8-K | 8-K | 8.01 | 0000950170-23-001185 | 001-41583 | 23553147 | 34 | 173247 | 1 | 1 |
| 2023-01-17 | 4/A | xslF345X03/ownership.xml | 0001493152-23-001702 | 4625 | ||||||
| 2023-01-05 | SC 13G | formsc13g.htm | 0001493152-23-000441 | 005-93853 | 23509780 | 34 | 103032 | |||
| 2023-01-04 | 4 | xslF345X03/ownership.xml | 0001493152-23-000227 | 8087 | ||||||
| 2023-01-04 | 4 | xslF345X03/ownership.xml | 0001493152-23-000226 | 11046 | ||||||
| 2023-01-04 | 4 | xslF345X03/ownership.xml | 0001493152-23-000225 | 6972 | ||||||
| 2023-01-04 | 4 | xslF345X03/ownership.xml | 0001493152-23-000223 | 6958 | ||||||
| 2023-01-04 | 4 | xslF345X03/ownership.xml | 0001493152-23-000224 | 6902 | ||||||
| 2023-01-04 | 4 | xslF345X03/ownership.xml | 0001493152-23-000222 | 6964 | ||||||
| 2023-01-04 | 4 | xslF345X03/ownership.xml | 0001493152-23-000221 | 6844 | ||||||
| 2022-12-30 | 424B4 | 424B4 | 0001564590-22-040078 | 333-268482 | 221502162 | 33 | 9110075 | |||
| 2022-12-29 | CERT | 8A_Cert_COYA.pdf | 0001354457-22-000801 | 001-41583 | 221496959 | 34 | 217245 | |||
| 2022-12-28 | SEC STAFF LETTER | filename1.pdf | 9999999997-22-005061 | 274880 | ||||||
| 2022-12-28 | EFFECT | xslEFFECTX01/primary_doc.xml | S-1,,2022-12-28 17:15:00 | 9999999995-22-003654 | 333-268482 | 221496252 | 33 | 1692 | ||
| 2022-12-28 | 3 | xslF345X02/ownership.xml | 0001493152-22-036723 | 3863 | ||||||
| 2022-12-28 | 3 | xslF345X02/ownership.xml | 0001493152-22-036718 | 12360 | ||||||
| 2022-12-28 | 3 | xslF345X02/ownership.xml | 0001493152-22-036717 | 14269 | ||||||
| 2022-12-28 | 3 | xslF345X02/ownership.xml | 0001493152-22-036714 | 12688 | ||||||
| 2022-12-28 | 3 | xslF345X02/ownership.xml | 0001493152-22-036713 | 13908 | ||||||
| 2022-12-28 | 3 | xslF345X02/ownership.xml | 0001493152-22-036712 | 13244 | ||||||
| 2022-12-28 | 3 | xslF345X02/ownership.xml | 0001493152-22-036711 | 12622 | ||||||
| 2022-12-28 | 3 | xslF345X02/ownership.xml | 0001493152-22-036709 | 13163 | ||||||
| 2022-12-27 | 8-A12B | 8-A12B | 0000950123-22-012756 | 001-41583 | 221490433 | 34 | 35598 | |||
| 2022-12-23 | CORRESP | filename1.htm | 0001564590-22-039680 | 15284 | ||||||
| 2022-12-23 | CORRESP | filename1.htm | 0001564590-22-039678 | 16197 | ||||||
| 2022-12-13 | CORRESP | filename1.htm | 0001564590-22-039244 | 122548 | ||||||
| 2022-12-13 | S-1/A | S-1/A | 0001564590-22-039242 | 333-268482 | 221458154 | 33 | 9827861 | |||
| 2022-12-09 | UPLOAD | filename1.pdf | 0000000000-22-013298 | 44365 | ||||||
| 2022-12-06 | FWP | FWP | 0001564590-22-039079 | 333-268482 | 221447995 | 34 | 12661359 | |||
| 2022-12-05 | CORRESP | filename1.htm | 0001564590-22-038994 | 29934 | ||||||
| 2022-12-05 | S-1/A | S-1/A | 0001564590-22-038993 | 333-268482 | 221443806 | 33 | 11672581 | |||
| 2022-11-29 | UPLOAD | filename1.pdf | 0000000000-22-012862 | 45690 | ||||||
| 2022-11-23 | SEC STAFF LETTER | filename1.pdf | 9999999997-22-004838 | 276163 | ||||||
| 2022-11-18 | CORRESP | filename1.htm | 0001564590-22-038043 | 37708 | ||||||
| 2022-11-18 | S-1 | S-1 | 0001564590-22-038040 | 333-268482 | 221402724 | 33 | 13985072 | |||
| 2022-11-04 | UPLOAD | filename1.pdf | 0000000000-22-012032 | 46682 | ||||||
| 2022-10-28 | DRSLTR | filename1.htm | 0000950123-22-010566 | 50105 | ||||||
| 2022-10-28 | DRS/A | filename1.htm | 0000950123-22-010565 | 377-06324 | 221343051 | 33 | 10134401 | |||
| 2022-10-19 | UPLOAD | filename1.pdf | 0000000000-22-011498 | 50881 | ||||||
| 2022-10-07 | DRSLTR | filename1.htm | 0000950123-22-010098 | 145326 | ||||||
| 2022-10-07 | DRS/A | filename1.htm | 0000950123-22-010095 | 377-06324 | 221301192 | 33 | 7329805 | |||
| 2022-09-15 | UPLOAD | filename1.pdf | 0000000000-22-010127 | 81581 | ||||||
| 2022-08-19 | DRS | filename1.htm | 0001564590-22-029826 | 377-06324 | 221181355 | 33 | 6229347 | |||
| 2022-05-20 | D | xslFormDX01/primary_doc.xml | 06b | 0001493152-22-014555 | 021-446377 | 22946228 | 33 | 14517 | ||
| 2021-01-05 | D | xslFormDX01/primary_doc.xml | 06b | 0001835022-21-000001 | 021-385191 | 21503341 | 33 | 10520 |
One latest value per concept from companyfacts (152 concepts). Full history stays in the JSON.
| Taxonomy | Tag | Label | Unit | Value | Start | End | FY | FP | Form | Filed | Accn |
|---|---|---|---|---|---|---|---|---|---|---|---|
| dei | EntityCommonStockSharesOutstanding | Entity Common Stock, Shares Outstanding | shares | 23.46M | 2026-11-05 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001193125-26-454478 | |
| dei | EntityPublicFloat | Entity Public Float | USD | 89.42M | 2025-06-30 | 2025 | FY | 10-K | 2026-03-16 | 0001193125-26-107281 | |
| us-gaap | AccountsPayableCurrent | Accounts Payable, Current | USD | 2.45M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001193125-26-454478 | |
| us-gaap | AccruedEmployeeBenefitsCurrent | Accrued Employee Benefits, Current | USD | 913,675 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001193125-26-454478 | |
| us-gaap | AccruedIncomeTaxesCurrent | Accrued Income Taxes, Current | USD | 723,852 | 2023-12-31 | 2024 | FY | 10-K | 2025-03-18 | 0000950170-25-040782 | |
| us-gaap | AccruedLiabilitiesCurrent | Accrued Liabilities, Current | USD | 1.78M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001193125-26-454478 | |
| us-gaap | AccruedProfessionalFeesCurrent | Accrued Professional Fees, Current | USD | 285,120 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001193125-26-454478 | |
| us-gaap | AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment | Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment | USD | 98,216 | 2024-12-31 | 2024 | FY | 10-K | 2025-03-18 | 0000950170-25-040782 | |
| us-gaap | AdditionalPaidInCapital | Additional Paid in Capital | USD | 119.99M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001193125-26-454478 | |
| us-gaap | AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue | APIC, Share-based Payment Arrangement, Increase for Cost Recognition | USD | 910,076 | 2026-07-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001193125-26-454478 |
| us-gaap | AllocatedShareBasedCompensationExpense | Share-based Payment Arrangement, Expense | USD | 4.05M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001193125-26-454478 |
| us-gaap | AmortizationOfFinancingCosts | Amortization of Debt Issuance Costs | USD | 997,367 | 2022-01-01 | 2022-12-31 | 2023 | FY | 10-K | 2024-03-19 | 0000950170-24-033161 |
| us-gaap | AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount | shares | 4.72M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001193125-26-454478 |
| us-gaap | Assets | Assets | USD | 39.32M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001193125-26-454478 | |
| us-gaap | AssetsCurrent | Assets, Current | USD | 39.07M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001193125-26-454478 | |
| us-gaap | CashAndCashEquivalentsAtCarryingValue | Cash and Cash Equivalents, at Carrying Value | USD | 35.80M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001193125-26-454478 | |
| us-gaap | CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations | USD | 35.80M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001193125-26-454478 | |
| us-gaap | CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect | USD | -11.02M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001193125-26-454478 |
| us-gaap | CommonStockParOrStatedValuePerShare | Common Stock, Par or Stated Value Per Share | USD/shares | 0 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001193125-26-454478 | |
| us-gaap | CommonStockSharesAuthorized | Common Stock, Shares Authorized | shares | 200.00M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001193125-26-454478 | |
| us-gaap | CommonStockSharesIssued | Common Stock, Shares, Issued | shares | 23.46M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001193125-26-454478 | |
| us-gaap | CommonStockSharesOutstanding | Common Stock, Shares, Outstanding | shares | 23.46M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001193125-26-454478 | |
| us-gaap | CommonStockValue | Common Stock, Value, Issued | USD | 2,346 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001193125-26-454478 | |
| us-gaap | ContractWithCustomerLiability | Contract with Customer, Liability | USD | 1.52B | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001193125-26-454478 | |
| us-gaap | ContractWithCustomerLiabilityRevenueRecognized | Contract with Customer, Liability, Revenue Recognized | USD | 729.03M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001193125-26-454478 |
| us-gaap | ConvertibleLongTermNotesPayable | Convertible Notes Payable, Noncurrent | USD | 12.97M | 2022-12-31 | 2023 | FY | 10-K | 2024-03-19 | 0000950170-24-033161 | |
| us-gaap | CurrentFederalTaxExpenseBenefit | Current Federal Tax Expense (Benefit) | USD | -718,582 | 2024-01-01 | 2024-12-31 | 2025 | FY | 10-K | 2026-03-16 | 0001193125-26-107281 |
| us-gaap | CurrentStateAndLocalTaxExpenseBenefit | Current State and Local Tax Expense (Benefit) | USD | 3,089 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-16 | 0001193125-26-107281 |
| us-gaap | DeferredFinanceCostsNoncurrentNet | Debt Issuance Costs, Noncurrent, Net | USD | 1.12M | 2022-12-31 | 2023 | FY | 10-K | 2024-03-19 | 0000950170-24-033161 | |
| us-gaap | DeferredRevenue | Deferred Revenue | USD | 0 | 2022-12-31 | 2023 | FY | 10-K | 2024-03-19 | 0000950170-24-033161 | |
| us-gaap | DeferredRevenueCurrent | Deferred Revenue, Current | USD | 1.16M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001193125-26-454478 | |
| us-gaap | DeferredTaxAssetsDeferredIncome | Deferred Tax Assets, Deferred Income | USD | 271,294 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-16 | 0001193125-26-107281 | |
| us-gaap | DeferredTaxAssetsLiabilitiesNet | Deferred Tax Assets, Net | USD | 0 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-16 | 0001193125-26-107281 | |
| us-gaap | DeferredTaxAssetsNet | Deferred Tax Assets, Net of Valuation Allowance | USD | 60 | 2022-12-31 | 2022 | FY | 10-K | 2023-03-29 | 0000950170-23-010599 | |
| us-gaap | DeferredTaxAssetsOperatingLossCarryforwards | Deferred Tax Assets, Operating Loss Carryforwards | USD | 5.98M | 2025-12-31 | 2025 | FY | 10-K | 2026-03-16 | 0001193125-26-107281 | |
| us-gaap | DeferredTaxAssetsTaxCreditCarryforwards | Deferred Tax Assets, Tax Credit Carryforwards | USD | 1.90M | 2025-12-31 | 2025 | FY | 10-K | 2026-03-16 | 0001193125-26-107281 | |
| us-gaap | DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost | Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-based Compensation Cost | USD | 645,393 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-16 | 0001193125-26-107281 | |
| us-gaap | DeferredTaxAssetsValuationAllowance | Deferred Tax Assets, Valuation Allowance | USD | 13.31M | 2025-12-31 | 2025 | FY | 10-K | 2026-03-16 | 0001193125-26-107281 | |
| us-gaap | DeferredTaxLiabilities | Deferred Tax Liabilities, Net | USD | 60 | 2022-12-31 | 2022 | FY | 10-K | 2023-03-29 | 0000950170-23-010599 | |
| us-gaap | DeferredTaxLiabilitiesPropertyPlantAndEquipment | Deferred Tax Liabilities, Property, Plant and Equipment | USD | -469 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-16 | 0001193125-26-107281 | |
| us-gaap | Depreciation | Depreciation | USD | 8,421 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001193125-26-454478 |
| us-gaap | EarningsPerShareBasic | Earnings Per Share, Basic | USD/shares | -1.05 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001193125-26-454478 |
| us-gaap | EarningsPerShareDiluted | Earnings Per Share, Diluted | USD/shares | -1.05 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001193125-26-454478 |
| us-gaap | EffectiveIncomeTaxRateContinuingOperations | Effective Income Tax Rate Reconciliation, Percent | pure | -0 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-16 | 0001193125-26-107281 |
| us-gaap | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent | pure | 0.21 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-16 | 0001193125-26-107281 |
| us-gaap | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Percent | pure | -0.244 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-16 | 0001193125-26-107281 |
| us-gaap | EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate | Effective Income Tax Rate Reconciliation, Change in Enacted Tax Rate, Percent | pure | 0 | 2024-01-01 | 2024-12-31 | 2024 | FY | 10-K | 2025-03-18 | 0000950170-25-040782 |
| us-gaap | EffectiveIncomeTaxRateReconciliationNondeductibleExpense | Effective Income Tax Rate Reconciliation, Nondeductible Expense, Percent | pure | -0.005 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-16 | 0001193125-26-107281 |
| us-gaap | EffectiveIncomeTaxRateReconciliationOtherAdjustments | Effective Income Tax Rate Reconciliation, Other Adjustments, Percent | pure | 0 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-16 | 0001193125-26-107281 |
| us-gaap | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Percent | pure | -0.002 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-16 | 0001193125-26-107281 |
| us-gaap | EffectiveIncomeTaxRateReconciliationTaxCreditsResearch | Effective Income Tax Rate Reconciliation, Tax Credit, Research, Percent | pure | -0.067 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-16 | 0001193125-26-107281 |
| us-gaap | EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions | Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount | USD | 4.50M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001193125-26-454478 | |
| us-gaap | FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues | Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Issuances | USD | 12.97M | 2023-01-01 | 2023-12-31 | 2024 | FY | 10-K | 2025-03-18 | 0000950170-25-040782 |
| us-gaap | FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPeriodIncreaseDecrease | Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Period Increase (Decrease) | USD | 2.50M | 2022-01-01 | 2022-12-31 | 2023 | FY | 10-K | 2024-03-19 | 0000950170-24-033161 |
| us-gaap | FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue | Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability Value | USD | 12.97M | 2022-12-31 | 2024 | FY | 10-K | 2025-03-18 | 0000950170-25-040782 | |
| us-gaap | FederalIncomeTaxExpenseBenefitContinuingOperations | Federal Income Tax Expense (Benefit), Continuing Operations | USD | 0 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-16 | 0001193125-26-107281 |
| us-gaap | GeneralAndAdministrativeExpense | General and Administrative Expense | USD | 8.62M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001193125-26-454478 |
| us-gaap | ImpairmentOfLongLivedAssetsHeldForUse | Impairment of Long-Lived Assets Held-for-use | USD | 0 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-16 | 0001193125-26-107281 |
| us-gaap | IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest | Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest | USD | -24.46M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001193125-26-454478 |
| us-gaap | IncomeTaxesPaid | Income Taxes Paid | USD | 700,000 | 2024-01-01 | 2024-12-31 | 2024 | FY | 10-K | 2025-03-18 | 0000950170-25-040782 |
| us-gaap | IncomeTaxesPaidNet | Income Taxes Paid, Net | USD | -730,581 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-16 | 0001193125-26-107281 |
| us-gaap | IncomeTaxesReceivable | Income Taxes Receivable, Current | USD | 730,581 | 2024-12-31 | 2025 | FY | 10-K | 2026-03-16 | 0001193125-26-107281 | |
| us-gaap | IncomeTaxExpenseBenefit | Income Tax Expense (Benefit) | USD | 3,089 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-16 | 0001193125-26-107281 |
| us-gaap | IncomeTaxPaidFederalAfterRefundReceived | IncomeTaxPaidFederalAfterRefundReceived | USD | -725,000 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-16 | 0001193125-26-107281 |
| us-gaap | IncomeTaxReceivable | Income Taxes Receivable | USD | 700,000 | 2024-12-31 | 2024 | FY | 10-K | 2025-03-18 | 0000950170-25-040782 | |
| us-gaap | IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance | Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Amount | USD | 5.18M | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-16 | 0001193125-26-107281 |
| us-gaap | IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate | Effective Income Tax Rate Reconciliation at Federal Statutory Income Tax Rate, Amount | USD | -4.46M | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-16 | 0001193125-26-107281 |
| us-gaap | IncomeTaxReconciliationNondeductibleExpense | Effective Income Tax Rate Reconciliation, Nondeductible Expense, Amount | USD | 103,368 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-16 | 0001193125-26-107281 |
| us-gaap | IncomeTaxReconciliationOtherAdjustments | Effective Income Tax Rate Reconciliation, Other Adjustments, Amount | USD | -775 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-16 | 0001193125-26-107281 |
| us-gaap | IncomeTaxReconciliationStateAndLocalIncomeTaxes | Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Amount | USD | 36,708 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-16 | 0001193125-26-107281 |
| us-gaap | IncomeTaxReconciliationTaxCreditsResearch | Effective Income Tax Rate Reconciliation, Tax Credit, Research, Amount | USD | 1.41M | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-16 | 0001193125-26-107281 |
| us-gaap | IncreaseDecreaseInAccountsPayable | Increase (Decrease) in Accounts Payable | USD | 1.39M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001193125-26-454478 |
| us-gaap | IncreaseDecreaseInAccruedLiabilities | Increase (Decrease) in Accrued Liabilities | USD | -959,216 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001193125-26-454478 |
| us-gaap | IncreaseDecreaseInDeferredRevenue | Increase (Decrease) in Deferred Revenue | USD | -729,026 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001193125-26-454478 |
| us-gaap | IncreaseDecreaseInOtherNoncurrentAssets | Increase (Decrease) in Other Noncurrent Assets | USD | 120,441 | 2026-01-01 | 2026-06-30 | 2026 | Q2 | 10-Q | 2026-08-11 | 0001193125-26-343481 |
| us-gaap | IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets | Increase (Decrease) in Prepaid Expense and Other Assets | USD | 151,827 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001193125-26-454478 |
| us-gaap | LaborAndRelatedExpense | Labor and Related Expense | USD | 1.84M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001193125-26-454478 |
| us-gaap | Liabilities | Liabilities | USD | 5.75M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001193125-26-454478 | |
| us-gaap | LiabilitiesAndStockholdersEquity | Liabilities and Equity | USD | 39.32M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001193125-26-454478 | |
| us-gaap | LiabilitiesCurrent | Liabilities, Current | USD | 5.39M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001193125-26-454478 | |
| us-gaap | NetCashProvidedByUsedInFinancingActivities | Net Cash Provided by (Used in) Financing Activities | USD | 10.71M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001193125-26-454478 |
| us-gaap | NetCashProvidedByUsedInInvestingActivities | Net Cash Provided by (Used in) Investing Activities | USD | -909,896 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001193125-26-454478 |
| us-gaap | NetCashProvidedByUsedInOperatingActivities | Net Cash Provided by (Used in) Operating Activities | USD | -20.82M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001193125-26-454478 |
| us-gaap | NetIncomeLoss | Net Income (Loss) Attributable to Parent | USD | -24.46M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001193125-26-454478 |
| us-gaap | NumberOfOperatingSegments | Number of Operating Segments | Segment | 1 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001193125-26-454478 |
| us-gaap | OperatingExpenses | Operating Expenses | USD | 26.36M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001193125-26-454478 |
| us-gaap | OperatingIncomeLoss | Operating Income (Loss) | USD | -25.64M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001193125-26-454478 |
| us-gaap | OtherAccruedLiabilitiesCurrent | Other Accrued Liabilities, Current | USD | 43,139 | 2025-12-31 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001193125-26-454478 | |
| us-gaap | OtherAssetsNoncurrent | Other Assets, Noncurrent | USD | 244,727 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001193125-26-454478 | |
| us-gaap | OtherGeneralAndAdministrativeExpense | Other General and Administrative Expense | USD | 3.99M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001193125-26-454478 |
| us-gaap | OtherNonoperatingIncomeExpense | Other Nonoperating Income (Expense) | USD | 1.17M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001193125-26-454478 |
| us-gaap | OtherPrepaidExpenseCurrent | Other Prepaid Expense, Current | USD | 140,428 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001193125-26-454478 | |
| us-gaap | PaymentOfFinancingAndStockIssuanceCosts | Payment of Financing and Stock Issuance Costs | USD | 2.70M | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-16 | 0001193125-26-107281 |
| us-gaap | PaymentsForRepurchaseOfInitialPublicOffering | Payments for Repurchase of Initial Public Offering | USD | 341,901 | 2021-01-01 | 2021-12-31 | 2022 | FY | 10-K | 2023-03-29 | 0000950170-23-010599 |
| us-gaap | PaymentsForRepurchaseOfPrivatePlacement | Payments for Repurchase of Private Placement | USD | 65,385 | 2022-01-01 | 2022-03-31 | 2023 | Q1 | 10-Q | 2023-05-10 | 0000950170-23-020076 |
| us-gaap | PaymentsOfDebtIssuanceCosts | Payments of Debt Issuance Costs | USD | 997,367 | 2022-01-01 | 2022-12-31 | 2023 | FY | 10-K | 2024-03-19 | 0000950170-24-033161 |
| us-gaap | PaymentsOfFinancingCosts | Payments of Financing Costs | USD | 244,727 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001193125-26-454478 |
| us-gaap | PaymentsToAcquireInProcessResearchAndDevelopment | Payments to Acquire in Process Research and Development | USD | 909,896 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001193125-26-454478 |
| us-gaap | PreferredStockLiquidationPreferenceValue | Preferred Stock, Liquidation Preference, Value | USD | 10.04M | 2022-12-31 | 2022 | FY | 10-K | 2023-03-29 | 0000950170-23-010599 | |
| us-gaap | PreferredStockParOrStatedValuePerShare | Preferred Stock, Par or Stated Value Per Share | USD/shares | 0 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001193125-26-454478 | |
| us-gaap | PreferredStockSharesAuthorized | Preferred Stock, Shares Authorized | shares | 10.00M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001193125-26-454478 | |
| us-gaap | PreferredStockSharesIssued | Preferred Stock, Shares Issued | shares | 0 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001193125-26-454478 | |
| us-gaap | PreferredStockSharesOutstanding | Preferred Stock, Shares Outstanding | shares | 0 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001193125-26-454478 | |
| us-gaap | PreferredStockValue | Preferred Stock, Value, Issued | USD | 8.79M | 2022-12-31 | 2023 | FY | 10-K | 2024-03-19 | 0000950170-24-033161 | |
| us-gaap | PrepaidExpenseAndOtherAssetsCurrent | Prepaid Expense and Other Assets, Current | USD | 3.27M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001193125-26-454478 | |
| us-gaap | PrepaidInsurance | Prepaid Insurance | USD | 205,038 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001193125-26-454478 | |
| us-gaap | ProceedsFromConvertibleDebt | Proceeds from Convertible Debt | USD | 10.47M | 2022-01-01 | 2022-12-31 | 2023 | FY | 10-K | 2024-03-19 | 0000950170-24-033161 |
| us-gaap | ProceedsFromIssuanceInitialPublicOffering | Proceeds from Issuance Initial Public Offering | USD | 14.25M | 2023-01-01 | 2023-12-31 | 2024 | FY | 10-K | 2025-03-18 | 0000950170-25-040782 |
| us-gaap | ProceedsFromIssuanceOfCommonStock | Proceeds from Issuance of Common Stock | USD | 10.95M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001193125-26-454478 |
| us-gaap | ProceedsFromStockOptionsExercised | Proceeds from Stock Options Exercised | USD | 38,274 | 2025-01-01 | 2025-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001193125-26-454478 |
| us-gaap | ProceedsFromWarrantExercises | Proceeds from Warrant Exercises | USD | 2.14M | 2024-01-01 | 2024-12-31 | 2025 | FY | 10-K | 2026-03-16 | 0001193125-26-107281 |
| us-gaap | ProfitLoss | Net Income (Loss), Including Portion Attributable to Noncontrolling Interest | USD | -24.46M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001193125-26-454478 |
| us-gaap | PropertyPlantAndEquipmentGross | Property, Plant and Equipment, Gross | USD | 136,804 | 2024-12-31 | 2024 | FY | 10-K | 2025-03-18 | 0000950170-25-040782 | |
| us-gaap | PropertyPlantAndEquipmentNet | Property, Plant and Equipment, Net | USD | 2,807 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001193125-26-454478 | |
| us-gaap | ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost | Research and Development Expense (Excluding Acquired in Process Cost) | USD | 17.70M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001193125-26-454478 |
| us-gaap | ResearchAndDevelopmentInProcess | Research and Development in Process | USD | 525,000 | 2022-01-01 | 2022-12-31 | 2022 | FY | 10-K | 2023-03-29 | 0000950170-23-010599 |
| us-gaap | RetainedEarningsAccumulatedDeficit | Retained Earnings (Accumulated Deficit) | USD | -86.43M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001193125-26-454478 | |
| us-gaap | Revenues | Revenues | USD | 729,026 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001193125-26-454478 |
| us-gaap | ShareBasedCompensation | Share-based Payment Arrangement, Noncash Expense | USD | 4.05M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001193125-26-454478 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Exercise Price | USD/shares | 3.48 | 2022-12-31 | 2022 | FY | 10-K | 2023-03-29 | 0000950170-23-010599 | |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate | pure | 0 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001193125-26-454478 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate | pure | 1.003 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001193125-26-454478 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate | pure | 0.039 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001193125-26-454478 |
| us-gaap | SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1 | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value | USD | 1.74M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001193125-26-454478 | |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number | shares | 2.63M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001193125-26-454478 | |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price | USD/shares | 5.19 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001193125-26-454478 | |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value | USD | 3,438 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001193125-26-454478 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period | shares | 211 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001193125-26-454478 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross | shares | 922,428 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001193125-26-454478 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue | Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value | USD | 1.95M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001193125-26-454478 | |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber | Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number | shares | 3.89M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001193125-26-454478 | |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice | Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price | USD/shares | 5.28 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001193125-26-454478 | |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue | Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Aggregate Intrinsic Value | USD | 1.95M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001193125-26-454478 | |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber | Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Number | shares | 3.89M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001193125-26-454478 | |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice | Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Exercise Price | USD/shares | 5.28 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001193125-26-454478 | |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardPlanModificationIncrementalCompensationCost | Share-based Payment Arrangement, Plan Modification, Incremental Cost | USD | 1.00M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001193125-26-454478 |
| us-gaap | ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice | Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price | USD/shares | 1.09 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001193125-26-454478 |
| us-gaap | ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice | Share-based Compensation Arrangements by Share-based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price | USD/shares | 1.09 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001193125-26-454478 |
| us-gaap | ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice | Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price | USD/shares | 4.77 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001193125-26-454478 |
| us-gaap | ShortTermLeaseCost | Short-term Lease, Cost | USD | 30,000 | 2022-01-01 | 2022-12-31 | 2022 | FY | 10-K | 2023-03-29 | 0000950170-23-010599 |
| us-gaap | StateAndLocalIncomeTaxExpenseBenefitContinuingOperations | State and Local Income Tax Expense (Benefit), Continuing Operations | USD | 3,089 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-16 | 0001193125-26-107281 |
| us-gaap | StockholdersEquity | Stockholders' Equity Attributable to Parent | USD | 33.57M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001193125-26-454478 | |
| us-gaap | StockholdersEquityNoteStockSplitConversionRatio1 | Stockholders' Equity Note, Stock Split, Conversion Ratio | pure | 0.176 | 2022-12-01 | 2022-12-31 | 2023 | FY | 10-K | 2024-03-19 | 0000950170-24-033161 |
| us-gaap | StockholdersEquityNoteSubscriptionsReceivable | Stockholders' Equity Note, Subscriptions Receivable | USD | 11,250 | 2023-12-31 | 2024 | FY | 10-K | 2025-03-18 | 0000950170-25-040782 | |
| us-gaap | StockIssuedDuringPeriodSharesIssuedForServices | Stock Issued During Period, Shares, Issued for Services | shares | 10,000 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-16 | 0001193125-26-107281 |
| us-gaap | StockIssuedDuringPeriodSharesStockOptionsExercised | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period | shares | 666 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001193125-26-454478 |
| us-gaap | StockIssuedDuringPeriodValueNewIssues | Stock Issued During Period, Value, New Issues | USD | 4.94M | 2024-04-01 | 2024-06-30 | 2025 | Q3 | 10-Q | 2025-11-12 | 0001193125-25-276058 |
| us-gaap | StockIssuedDuringPeriodValueStockOptionsExercised | Stock Issued During Period, Value, Stock Options Exercised | USD | 19,137 | 2025-07-01 | 2025-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001193125-26-454478 |
| us-gaap | UnrecognizedTaxBenefits | Unrecognized Tax Benefits | USD | 0 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001193125-26-454478 | |
| us-gaap | UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense | Unrecognized Tax Benefits, Income Tax Penalties and Interest Expense | USD | 0 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001193125-26-454478 |
| us-gaap | WeightedAverageNumberOfDilutedSharesOutstanding | Weighted Average Number of Shares Outstanding, Diluted | shares | 23.19M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001193125-26-454478 |
| us-gaap | WeightedAverageNumberOfSharesOutstandingBasic | Weighted Average Number of Shares Outstanding, Basic | shares | 23.19M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001193125-26-454478 |